title: Valproate-induced eosinophilia in children with epilepsy: role of interleukin-5.
abstract: Interleukin-5 contributes both in eosinophilopoiesis and neural development. Serum interleukin-5 levels were measured with enzyme-linked immunosorbent assay technique in 68 children with epilepsy receiving sodium valproate monotherapy and compared with the levels of 60 healthy controls and 14 children with epilepsy receiving carbamazepine. Eosinophilia was observed in 35.3% of children receiving valproate. Interleukin-5 in valproate users was significantly higher compared with children receiving carbamazepine and controls. Valproate users who exhibited eosinophilia had higher interleukin-5 levels compared with those without eosinophilia. However, the interleukin-5 level was also elevated, although to a lesser degree, in children without eosinophilia. The majority of valproate responders had high interleukin-5 levels. A positive correlation between interleukin-5 levels and the eosinophil count was also noted. We postulate that valproate contributes to the pathogenesis of eosinophilia, probably inducing interleukin-5 production. The finding that serum interleukin-5 was significantly elevated in valproate responders and even in valproate users without eosinophilia suggests that the increase in interleukin-5 might represent one of valproate's antiepileptic mechanisms.
authors.affiliation: Department of Child Health, University Hospital of Ioannina, Ionnina, Greece. me00350@cc.uoi.gr
authors.forename: Alexandros C
authors.initials: AC
authors.lastname: Makis
authors.forename: Meropi
authors.initials: M
authors.lastname: Tzoufi
authors.forename: Maria D
authors.initials: MD
authors.lastname: Kateri
authors.forename: Konstantinos L
authors.initials: KL
authors.lastname: Bourantas
authors.forename: Zoe L
authors.initials: ZL
authors.lastname: Papadopoulou
mesh_terms: D000293:Adolescent; D000927:Anticonvulsants / Q000009:adverse effects*; D002220:Carbamazepine / Q000627:therapeutic use; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D004802:Eosinophilia / Q000097:blood* / Q000139:chemically induced*; D004827:Epilepsy / Q000097:blood* / Q000188:drug therapy; D005260:Female; D006801:Humans; D015848:Interleukin-5 / Q000097:blood*; D008297:Male; D014635:Valproic Acid / Q000009:adverse effects*
chemical_list: D000927:Anticonvulsants; D015848:Interleukin-5; D002220:Carbamazepine; D014635:Valproic Acid